Cyclic nucleotide research, from the standpoints of both organic chemistry and mode of action in the physiology of the mammalian cell, remains a relatively new field. Cyclic A M P was first described by Sutherland and Ralll as the mediator of the hepatic glycogenolytic effect of epinephrine and glucagon and is now recognized as a versatile regulatory agent mediating a host of hormonal effects. Research has uncovered a vast pool of potential effects of the cyclic nucleotides in cellular differentiation, dedifferentiation, and transformation, all of which implicate various enzymes, protein synthetic mechanisms, and viruses.
ENHANCEMENT OF INFLUENZA VIRUS GROWTH BY A CYCLIC NUCLEOTIDE

Effective Dose Level
Type A influenza A/AA/6/60 (H,N,) was plaque purified and pools were made by growing the virus in Il-day embryonated eggs at 33°C. Procedures used to prepare primary chick kidney cells (PCKC) have been described elsewhere.8 Monolayers of these cells were established in 5 days using growth medium 199 with 10% calf serum.
The growth media of the established chick kidney monolayer was discarded, the cells were washed once in prewarmed Hank's balanced salt solution, and the virus inoculum was allowed to adsorb for 1 hr at room temperature. Residual virus was removed, the cell sheet washed with Hank's balanced salt solution, and fresh maintenance media composed of double-strength Eagle's basal solution, but no serum, was added.
Work was initiated with 3':5'-cyclic adenosine monophosphate (CAMP). However, its derivative Ne,0*-dibutyryladenosine-3':5'-cyclic monophosphate (dcAMP) was substituted when published reports showed that its lipolytic properties made it more permeable for the cell membrane8 and that it inhibits phosphodiesterase catalyzed breakdown of cellular cAMP.'O The effect of dcAMP on influenza virus multiplication in primary chick kidney cells (PCKC) was followed by determining virus yield in untreated cells and in those treated with different doses of dcAMP. TABLE I shows the results of a typical experiment. It is evident that enhancement in hemagglutinin (HA) yield is apparent at 24 hr postinfection (pi.), with either 25 mM or 5 mM concentrations when compared to yield from untreated cells. The results a t 48 hr p.i. were similar in both groups.
In general the compound was added just before inoculation of PCKC with lo4 TCID,,/ml of Type A influenza virus (A/AA/6/60-H,N2). Pretreatment of cells for up to 24 hr prior to infection did not seem to alter appreciably the effect of dcAMP on the course of infection. Under similar conditions, enhancement of HA production was also apparent upon infection of PCKC with Type B influenza virus (B/Palau/3/7 1 ).
Effect of Virus Dose
Since the enhancing effect of dcAMP was followed at only one level of virus inoculum, studies were undertaken to compare the effect of the dose of influenza virus on the yield of HA in treated and untreated PCKC. Results presented in TABLE 2 demonstrate clearly that the enhancing effect of dcAMP on the yield is dose-dependent. At lo-, dilution of influenza virus pool (corresponding to a multiplicity of l0:l). there was no significant difference in the yield between control and dcAMPtreated PCKC. However, at dilution, there is a definite increase in H A yield in dcAMP-treated cells as compared to untreated cells at 48 hr p.i. At lo-' and dilution of influenza-virus, a significant enhancement in HA yield is apparent in dcAMP-treated cells a t both 24 and 48 hr p.i.
Serial Passage with dcAMP
Influenza virus was passed serially in treated and untreated PCKC holding constant both the concentration of compound (2.5 mM) and the dilution of virus The design of the experiment was to pass the virus every 48 hr p.i. and use the yield to initiate the next passage. Results of the rapid serial passages of the A/AA/6/60-H2N2 strain is illustrated in FIGURE 1. It is quite evident under the planned experimental design that upon serial passage in untreated cells, the virus yield was not enough to initiate the 3rd passage and virus could not be detected by hemagglutinin. However, in the dcAMP-treated cultures due to enhancement reported earlier, the virus persisted and vigorous growth was evident throughout serial passage. Infectivity yield, as shown in FIGURE 2, was sustained in treated cells but declined sharply, and eventually no infectious virus was detected in the untreated cells. In addition the neuraminidase activity of influenza virus was also enhanced in the dcAMP-treated cells as compared to the untreated cells.
The amplification of growth of influenza virus has substantiation on the basis of replication of certain RNA tumor virus-like particles in cell culture. For instance, it was shown that treatment of Chinese hamster cells with dcAMP led to formation of typical C-type particles containing 70-S RNA and an R N A tumor virus-like, RNA-directed, DNA polymerase activity." Treatment with the dcAMP did increase C-type particle formation in mouse leukemic L5178 Y/R lymphoblast 4 hr after start of treatment, this because of an apparent increase in the rate of viral maturation rather than induction." onated eggs, or that two blind passages were required before positive isolation.
ISOLATION FREQUENCY OF INFLUENZA VIRUS BY dcAMP
Amplification of influenza virus multiplication was also evident by the increase in frequency of isolation of influenza virus from nasopharyngeal swabs obtained from cases of clinical influenza as illustrated in TABLE 3. Isolation frequency in permissive cell cultures, such as primary chick kidney or primary monkey kidney cells was increased by treatment with dcAMP. Not only can the rate of isolation be increased by 30%, but also the time-course of incubation can be considerably shortened to approximately 24 hr after inoculation of clinical specimens. Hemadsorption and hemagglutination are evident during this short interval in the dcAMP treated cultures only, which is of tremendous advantage in terms of rapid isolation and identification in terms of influenza outbreaks.
HOST-DEPENDENT ENHANCEMENT
Results presented in TABLE 4 show that the enhancement of growth of influenza virus was reproducible in all permissive primary cell lines tested, but not in nonper- missive continuous cell lines. I n general, primary cultures, which usually display density-dependent inhibition of growth, have an increase in cAMP levels at confluency, whereas continuous aneuploid cells have a decrease in cAMP levels at high density. Hence, it is possible to speculate that in heteroploid cell lines, the nonpermissive state can be related to the level of intracellular CAMP, which is definitely lower and does not fluctuate appreciably during cellular growth or by the exogenous addition of cyclic nucleotides. In addition, the data illustrated in TABLE 4 show that addition of dcAMP to different permissive hosts infected with parainfluenza virus Type I (Sendai strain) did not result in any alteration of growth of the virus, since no enhancement or inhibition was demonstrated. Serial passage of Sendai virus in dcAMP-treated PCKC resulted in gradual decrease of infectious yield and eventual loss of virus infectivity (FIGURE 3 ). 
SPECIFICITY O F T H E STIMULATION O F GROWTH O F INFLUENZA VIRUS
In order to test the specificity of the enhancing effect of dcAMP on influenza viral replication in PCKC, a number of related compounds known to raise cellular cAMP levels by actions on the catalytic formation or breakdown of the cyclic nucleotide were used in serial passage of influenza virus-infected cells in order to duplicate the results obtained with dcAMP. The results presented in FIGURES 4 and 5 indicate that the effects on enhanced viral synthesis is specific to accumulation of cellular CAMP. Compounds known to raise cellular cAMP levels by actions on the catalytic formation or breakdown of the cyclic nucleotide were utilized in serial passage experiments in attempts to duplicate the results obtained with dcAMP. Rapid serial passages of the A/AA/6/60-H2N2 strain of influenza virus were initiated as described previously. Solutions of test agents made in double strength Eagle's medium were added at the time of infection, and cells were incubated in their presence for 48 hr. Results obtained indicate that the effect on enhanced viral growth is one mediated by cellular CAMP.
The adenyl cyclase of many cell systems generates an accumulation of endogenous cAMP as a result of stimulation by catecholamines and sodium fluoride.I3 Inhibition of phosphodiesterase catalyzed cellular cAMP breakdown by methylxanthine treatment accomplishes the same effect." Theophylline and sodium fluoride treatment of PCKC resulted in an effect on virus titer similar to that of addition of dcAMP to cell cultures. Furthermore, the presence of theophylline was shown, within the limits of this system, to potentiate the effect of 2.5 mM dcAMP on the outcome of infection. An adenyl cyclase response to catecholamine stimulation has been documented by Sutherland and R o b i n~o n '~ in a variety of cells. The adrenergic character of the response has been established.Is The net effect of the P-adrenergic agonist isoproterenol and the mixed stimulator epinephrine in the infected PCKC was an acceleration of infectious yield in serial passage. A similar effect of epinephrine was shown on SV,,-transformed WI-38 fibroblasts, where it was far in excess of that of normal WI-38." The competitive interaction between epinephrine and the /3-adrenergic antagonist propranolol has been studied in detail by Biel and Lum.18 Recently, propranolol has been utilized to abolish the P-adrenergic stimulation of human adipocyte lipolysis by epinephrine.' The present study has shown that enhancement of influenza yield during serial passage in epinephrine-treated PCKC could also be abolished by treatment with propranolol. Propranolol itself did not promote the persistence of influenza under similar conditions. Of interest is the fact that although no a-adrenergic antagonist was studied, other experimenters have shown a potentiation of the stimulatory action of epinephrine utilizing the a-adrenergic blocking agent phentolamine.'O No similar effect on influenza biosynthesis in the PCKC could be detected using sodium-N-butyrate or 5'-AMP at several concentrations. In addition, another cyclic nucleotide guanosine 3':5'-cyclic monophosphate (cGMP) did not alter the course of infection in PCKC since no enhancement or inhibition was observed with this compound.
THE INFLUENCE O F dcAMP O N MACROMOLECULAR SYNTHESIS OF VIRUS-INFECTED CELLS
The nature of the enhancement of influenza virus replication by treatment of PCKC with dcAMP was investigated and related to the overall rates of RNA and protein synthesis." FIGURE 6 shows the results of a typical experiment in which TCA-precipitable radioactivity of dcAMP-treated infected and uninfected cultures is presented as a percentage of corresponding infected or uninfected control cell levels. Total infected cell protein synthesis was observed to undergo a period of enhancement roughly between 4 and 8 hr p.i. in the presence of dcAMP. I n contrast, incubation of PCKC with dcAMP results in a short-lived burst of protein synthesis immediately after addition of compound to the untreated cells. Thereafter, protein synthesis is affected only slightly. The timing of enhancement of infected-cell protein synthesis resembles the pattern obtained from use of dcAMP in the biological studies of time course of treatment with the cyclic nucleotide and resultant virus yield. Monitoring acid-soluble radioactivity indicated that dcAMP treatment resulted in an initial increase in precursor uptake immediately following addition of compound, and preceding the period of enhancement seen in TCA-precipitable radioactivity. A consistently slight enhancement of precursor uptake throughout infection is characteristic of infected and uninfected cell incubated with dcAMP.
From the pattern of protein synthesis observed, it is unlikely that enhancement of synthesis is due simply to alteration of cell permeability to precursors early in infection but to specific enhancement of virus-induced protein synthesis.
The effect of treatment upon RNA synthesis of infected cells was investigated in a similar manner. In both infected and noninfected cultures, a pattern of depression of both uridine incorporation into TCA-precipitable material and uridine uptake can be observed. Data in FIGURE 7 is given as percentages of corresponding untreated control cultures as before. The inhibition of uridine incorporation into RNA of infected cells was never seen to be of the extent observed in the uninfected cultures. Because close parallels were always obtained between uridine incorporation and uptake, it seemed apparent that the decreased RNA synthesis of both uninfected and infected PCKC was due to the interference with the uptake of uridine affected by the dibutyryl compound. This observation has substantiation elsewhere in the literature.20 It is not clear at this state, whether the phenomenon of viral stimulation observed can be related only to specific enhancements of viral proteins, but it was demonstrated recently that exogenous addition of compounds that enhance intracellular CAMP also enhances antibody synthesis without elevating DNA and RNA synthesis."
EFFECTS OF dcAMP ON GROWTH O F Herpesvirus hominis TYPE 2
Experiments were designed to study the effect of dcAMP on the growth of a DNA virus, Herpesvirus hominis ( H V H ) Type 2 (Curtis strain) in PCKC. This virus was obtained from Dr. A. Nahmias (Emory University, Atlanta, Ga.) and a plaquepurified pool was made in chick kidney cells incubated at 35°C. The design of this study was the same as presented earlier with influenza virus, in which dcAMP- treated and untreated cells were infected with dilution of HVH Type 2 (titer 10e.O PFU/ml). Adsorption and maintainance media consisted of 2 x Eagle's basal solution supplemented with 2% horse serum. The infectious yield was determined after 48 hr p.i. by titration of the harvest in tissue culture (TCID,,), or in 12-gm Swiss mice (Webster strain) using intracerebral inoculation (MLDSO). The results presented in TABLE 5 show a definite inhibition in the growth of infectious virus in treated cells as measured in mice or in cell culture by cytopathic changes. Furthermore, Herpesvirus hominis was lost after serial passages in treated cells, while in untreated cells, growth of virus was sustained. The inhibition of herpesvirus replication and cytopathic changes in PCKC by dcAMP could be attributed to induction of latency by high levels of intracellular CAMP. This assumption is based on the fact that the treatment of HVH-infected cells with dcAMP initiates only a few foci of cellular degeneration as compared to untreated infected cells where complete cytolysis was evident. In addition, the treated cells after prolonged incubation seem to have recovered from herpesvirus infection and appear to have similar morphology and density as control cells. Hence, it is possible to speculate that this inhibition can be related to the action of cyclic nucleotides promoting latency of a DNA virus since it is well documented that dcAMP markedly inhibited the induction of DNA synthesis by Type 12 adenovirus.a2 Replication of adenovirus Type 2 was also inhibited by dcAMP in three cell culture lines.23 The induction of cellular DNA synthesis and of adenovirus specific tumor antigen by oncogenic adenovirus can also be inhibited by addition of dcAMP. In addition, in isolating mutants of Salmonella typhimurium defective in adenyl cyclase or in CAMP-receptor protein, we noted that the mutants were lysogenized a t reduced frequency by phage P22.24 Lysogenation could be stepped-up to normal values by the addition of 1 mM cAMP to the culture of adenyl cyclase deficient mutants but not with others. An analogous mechanism was noted to function in the E. coli phage system in which cAMP and a catabolite-activator protein are evidently required directly to initiate transcription of cataboliterepressed host cistrons as well as of phage genes necessary for establishing latency.''
SUMMARY
The yield of influenza virus from infected primary chick kidney cells (PCKC) was enhanced by treatment with dcAMP. In addition, rapid serial passages of the virus in treated chick cells at low multiplicities did also exhibit maintenance of high virus titers. The action of dcAMP upon viral replication could be reproduced in the chick cells by treatment with various agents known to increase intracellular cAMP levels by differing mechanisms. Furthermore, an adrenergic component in the activation of the PCKC cAMP system is indicated by the effects of certain catecholamines on influenza virus yield. Dibutyryl cAMP was shown in the same host to inhibit rnultiplication of Herpesvirus horninis Type 2, and its effect on other cell-virus systems indicates that its action consists of some host-specific element(s).
